TTP LabTech Delivers Automated Chemistry System for Salt and Polymorph Screening to AstraZeneca
News Jan 28, 2009
TTP LabTech announced that it had successfully completed a major laboratory automation project with AstraZeneca. The project, which took over three years to complete, involved the design and build of a fully automated system for salt and polymorph screening of novel compounds.
The system completed its site acceptance test (SAT) late last year before coming on-line at AstraZeneca’s research facility in Sodertalje.
This system for synthesizing and analyzing crystalline materials was designed in partnership between AstraZeneca and TTP LabTech. The overall objectives were to increase throughput, to explore experimental space and to automate the analysis of huge amounts of data.
The project has been undertaken in stages, the first of which was a prototyping stage. This stage helped to minimize risk by tackling those design elements that carried the greatest number of unknowns early in the project.
The next stage was the full design and build of a single screening machine to demonstrate control, functionality, and consistency of the basic automated polymorph screening processes. Now TTP LabTech has been asked to replicate the entire system in order to double the overall throughput.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE